Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
9/24/2021
Snapshot of BMI System Financial Performance in H1/2021
9/24/2021
Recent Executive Moves
9/23/2021
Sihuan/Xuanzhu and SignalChem Announce Licensing Deal for SLC-391 in G...
9/23/2021
Guangzhou Pharma Eyes Public Listing of Subsidiaries
9/23/2021
Cytiva Triples Bioprocessing Single-Use Consumables Capacity in China
9/23/2021
Scopus Granted Chinese Patent for CpG-STAT3 Inhibitor DUET-02
9/23/2021
Innovent's sNDA for Sintilimab in Combo with Chemotherapy as First-L...
9/23/2021
Prevalence of Depressive Disorders and Treatment in China: A Cross-Sec...
9/22/2021
NMPA Issues Q2/2021 Drug Regulatory Statistics Report
9/22/2021
China-based CMS Joins BaseLaunch as Latest Partner
9/20/2021
Leading Chinese Pharma Players Move on the Korean Market
9/20/2021
CDE Solicits Public Comments on Draft of the Technical Guidelines for ...
9/20/2021
CNIPA Issues Interpretation of Administrative Adjudication of Patent L...
9/19/2021
WiCON Publishes the China Pharmaceutical Guide 2021 (16th Edition)
9/17/2021
Tarveda and SciClone Expand Partnership with a License Deal for HSP9...
9/17/2021
CDE Solicits Public Comments on the Draft Guidelines for Centralized M...
9/17/2021
Celsion and Hainan Poly Pharm Sign Agreement to Manufacture Celsion's ...
9/17/2021
Henlius's NDA for Novel Anti-PD-1 mAb Serplulimab as First-Line Treatm...
9/17/2021
CDE Issues Technical Guidance for Bioequivalence Study of 16 Drugs
9/17/2021
Recent Executive Moves
9/16/2021
Luye Pharma Ties Up with ESTEVE for Its Alzheimer's Patch in Spain
9/16/2021
Everest Medicines, Sinovent and SinoMab Enter Licensing Deal for Novel...
9/16/2021
AstraZeneca, Daiichi Sankyo Begin New Gastric Cancer Enhertu Trial in ...
9/16/2021
Asymchem and LaNova Medicines Form Partnership, Expanding Biological C...
9/16/2021
Chinese Pursuit of Avigan Patent Faces Pushback in Japan
9/16/2021
Zai Lab Expands U.S. Operations with Key Presence in Cambridge Biotec...
9/16/2021
Innovent Releases Phase 2 Results of Pemigatinib in Chinese Patients w...
9/16/2021
CDE Seeks Comments on Draft Chinese Translation of ICH Guideline E14
9/16/2021
CDE Publicizes the List of Reference Formulations for GQCE Studies (49...
9/16/2021
Takeaways from Recent Implementation of China's Patent Linkage System
Page:
113
/
719
Total number of articles:
21546
:
[First]
[<<]
[111]
[112]
[113]
[114]
[115]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit